Literature DB >> 2242539

Area-at-risk determination by technetium-99m-hexakis-2-methoxyisobutyl isonitrile in experimental reperfused myocardial infarction.

P M De Coster1, W Wijns, F Cauwe, A Robert, C Beckers, J A Melin.   

Abstract

In a canine model of reperfused myocardial infarction, we tested the hypothesis that after reperfusion, technetium-99m-hexakis-2-methoxyisobutyl isonitrile (Tc-MIBI) tomographic imaging still reflects occlusion blood flow when the tracer is injected before reperfusion. Nine anesthetized dogs underwent 2 hours of coronary occlusion followed by 3 hours of reperfusion ending by being killed. Reference coronary blood flow was determined by radioactive microspheres injected during occlusion and after reperfusion. Biopsies in normal and ischemic myocardium and single photon emission computed tomography were obtained during occlusion and after reperfusion. Circumferential profiles were applied to axial slices divided into 5-degree sectors. The sectors were divided into 3 groups selected on the occlusion acquisition (normal, mildly reduced, and severely reduced) and compared with the postreperfusion acquisition. Tissular Tc-MIBI kinetics was assessed both by Tc-MIBI time-activity curves of normal and ischemic tissue obtained by biopsy and by the relative gradient between normal, ischemic, and necrotic postmortem tissue samples. In biopsy samples, Tc-MIBI content remained unchanged during occlusion and after reperfusion in normal as well as in ischemic tissue (4,662 +/- 2,237 counts/min/mg vs. 4,599 +/- 1,577 counts/min/mg in normal tissue, NS; 941 +/- 903 counts/min/mg vs. 1,087 +/- 721 counts/min/mg in ischemic tissue, NS). In postmortem tissue samples, there was a good correlation between occlusion microsphere blood flow and Tc-MIBI activity (r = 0.91). In the necrotic samples, mean normalized Tc-MIBI activity (10 +/- 17%) was slightly higher than the normalized microsphere blood flow (3 +/- 3%, p less than 0.001) but markedly lower than the normalized microsphere reperfusion blood flow (63 +/- 31%, p less than 0.001). Comparing the single photon emission computed tomographic acquisitions before and after reperfusion, Tc-MIBI activity remained unchanged in normal as well as in mildly reduced or severely reduced segments. Thus, our data are consistent with the hypothesis that Tc-MIBI traces blood flow, does not redistribute significantly despite reperfusion, and can be used for imaging the area at risk.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2242539     DOI: 10.1161/01.cir.82.6.2152

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  16 in total

Review 1.  Comparison of Tl-201 with Tc-99m-labeled myocardial perfusion agents: technical, physiologic, and clinical issues.

Authors:  P Kailasnath; A J Sinusas
Journal:  J Nucl Cardiol       Date:  2001 Jul-Aug       Impact factor: 5.952

Review 2.  Role of nuclear cardiac imaging in myocardial infarction: postinfarction risk stratification.

Authors:  John J Mahmarian; Girish Dwivedi; Tultul Lahiri
Journal:  J Nucl Cardiol       Date:  2004 Mar-Apr       Impact factor: 5.952

3.  Effect of coronary reperfusion on technetium-99m methoxyisobutylisonitrile uptake by viable and necrotic myocardium in the dog.

Authors:  Y Merhi; J G Latour; A Arsenault; G Rousseau
Journal:  Eur J Nucl Med       Date:  1992

4.  The influence of gating on measurements of myocardium at risk and infarct size during acute myocardial infarction by tomographic technetium 99m-labeled sestamibi imaging.

Authors:  T F Christian; M K O'Connor; R B Glynn; P J Rogers; R J Gibbons
Journal:  J Nucl Cardiol       Date:  1995 May-Jun       Impact factor: 5.952

Review 5.  Rationale for the rational development of new cardiac imaging agents.

Authors:  D D Miller
Journal:  Ann Nucl Med       Date:  1993-11       Impact factor: 2.668

6.  Assessment of area at risk and efficacy of treatment in patients with acute coronary syndrome using 99mTc tetrofosmin imaging in humans.

Authors:  H Matsuo; S Watanabe; Y Nishida; T Matsubara; M Kano; A Sugiyama; Y Matsuno; H Oda; Y Kotoo; H Oohashi
Journal:  Ann Nucl Med       Date:  1993-11       Impact factor: 2.668

7.  99mTc-sestamibi kinetics predict myocardial viability in a perfused rat heart model.

Authors:  Zhonglin Liu; David R Okada; Gerald Johnson; Sonia D Hocherman; Delia Beju; Robert D Okada
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-10-19       Impact factor: 9.236

8.  Assessment of myocardium at risk with contrast enhanced steady-state free precession cine cardiovascular magnetic resonance compared to single-photon emission computed tomography.

Authors:  Peder Sörensson; Einar Heiberg; Nawsad Saleh; Frederic Bouvier; Kenneth Caidahl; Per Tornvall; Lars Rydén; John Pernow; Håkan Arheden
Journal:  J Cardiovasc Magn Reson       Date:  2010-04-30       Impact factor: 5.364

Review 9.  Assessment of left ventricular dysfunction by nuclear cardiology.

Authors:  J A Melin; W Wijns; J L Vanoverschelde; G R Heyndrickx
Journal:  Cardiovasc Drugs Ther       Date:  1994-05       Impact factor: 3.727

10.  Quantification of technetium 99m-labeled sestamibi single-photon emission computed tomography based on mean counts improves accuracy for assessment of relative regional myocardial blood flow: experimental validation in a canine model.

Authors:  Y H Liu; A J Sinusas; C Q Shi; M Y Shen; D P Dione; E N Heller; F J Wackers
Journal:  J Nucl Cardiol       Date:  1996 Jul-Aug       Impact factor: 5.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.